Albemarle (ALB) director converts deferred phantom stock into common shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Albemarle Corporation director Gerald A. Steiner reported conversions of deferred phantom stock into common shares. On February 18, 2026, he exercised phantom stock units in two transactions, settling 153 units and 781 units into the same number of Albemarle common shares at a stated price of $0.00 per share.
The phantom stock represents deferred director compensation under Albemarle’s non‑employee director stock compensation and deferral plans, with units converting on a 1‑for‑1 basis into common stock and including dividend equivalent rights. Following these transactions, Steiner’s directly held common and phantom stock balances increased as part of his compensation arrangements rather than open‑market purchases.
Positive
- None.
Negative
- None.
Insider Trade Summary
934 shares exercised/converted
Mixed
4 txns
Insider
STEINER GERALD A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Phantom Stock | 153 | $0.00 | -- |
| Exercise | Phantom Stock | 781 | $0.00 | -- |
| Exercise | Common Stock | 153 | $0.00 | -- |
| Exercise | Common Stock | 781 | $0.00 | -- |
Holdings After Transaction:
Phantom Stock — 10,408 shares (Direct);
Common Stock — 11,165 shares (Direct)
Footnotes (1)
- The reporting person settled 153 shares of Phantom Stock for the same number of shares of common stock. Phantom Stock units convert 1 for 1 into common stock. The reporting person settled 781 shares of Phantom Stock for the same number of shares of common stock. Represents deferred director compensation under the Albemarle Corporation 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors. Exerciseable in five annual installments beginning on February 15th of the year after the year in which the reporting person reached 65 years of age. No expiration date. Includes dividend equivalent rights earned based on total Phantom Stock units in Director's deferred stock account. Represents deferred director compensation under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors Exercisable in a single lump sum on February 15th of the calendar year after the year in which the reporting reached 65 years of age.
FAQ
What insider transaction did Albemarle (ALB) director Gerald A. Steiner report?
Gerald A. Steiner reported converting phantom stock into Albemarle common shares. On February 18, 2026, he settled 153 and 781 phantom stock units into the same number of common shares, reflecting the exercise of deferred compensation rights rather than open-market buying or selling.
Were Gerald A. Steiner’s Albemarle (ALB) transactions open-market stock purchases or sales?
They were not open-market trades; they were derivative exercises. The Form 4 shows transaction code M, indicating exercise or conversion of phantom stock units into common shares as part of deferred director compensation, with a reported price of $0.00 per share for these conversions.
What are Albemarle (ALB) phantom stock units held by director Gerald A. Steiner?
The phantom stock units represent deferred director compensation under Albemarle stock compensation and deferral plans. They convert one-for-one into common stock, can include dividend equivalent rights, and become exercisable based on age-related schedules, rather than being regular market-traded equity awards.
How do Albemarle (ALB) phantom stock units convert into common stock?
Albemarle phantom stock units convert into common stock on a one-for-one basis. For Gerald A. Steiner, the Form 4 explains that specified units were settled into the same number of common shares, with certain awards exercisable in installments or lump sums tied to when he reached age 65.
What plans govern Gerald A. Steiner’s Albemarle (ALB) deferred phantom stock?
His phantom stock is issued under Albemarle’s stock compensation and deferral election plans for non-employee directors. The Form 4 cites the 2013 and 2023 plans, which provide for deferred director compensation, dividend equivalent rights, and age-based exercisability with no stated expiration date.